SCHEMBL694402

SCHEMBL694402

CC(=O)Cc1cccc(OC(C)=O)c1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.58
LMNA P02545 1/20 0.58
ACHE P22303 4/20 0.53
PARP1 P09874 1/20 0.49
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PKM P14618 1/20 0.46
GAA P10253 1/20 0.45
CTBP2 P56545 1/20 0.45
CNR2 P34972 1/20 0.45
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
F10 P00742 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3877144 0.88 CYP3A4 (0.56) CYP3A4LMNAACHEPARP1KDM4E
SCHEMBL5394435 0.86 CYP3A4 (0.54) CYP3A4LMNAACHEPARP1MEN1
SCHEMBL31618740 0.86 CYP3A4 (0.54) CYP3A4LMNAACHEPARP1MEN1
SCHEMBL27655540 0.85 ACHE (0.56) LMNAACHEKMT2APOLBCTBP2
SCHEMBL4634509 0.85 SLC7A5 (0.55) CYP3A4LMNAACHEPARP1MEN1
SCHEMBL1416873 0.84 POLB (0.67) MEN1KMT2APOLBKDM4EALDH1A1
SCHEMBL202980 0.84 CYP3A4 (0.59) CYP3A4LMNAACHEPARP1MEN1
SCHEMBL9362791 0.84 CYP3A4 (0.59) CYP3A4LMNAACHEPARP1MEN1
SCHEMBL269177 0.84 CTBP2 (0.62) MEN1KMT2APOLBALDH1A1CTBP2
SCHEMBL3339215 0.84 CYP3A4 (0.59) CYP3A4LMNAACHEPARP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3210981-A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA 2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Theravance Respiratory Company, LLC (US) 2017-08-30 EP disclosed
EP-2421849-A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Theravance, Inc. (US) 2012-02-29 EP disclosed
WO-2010123766-A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITY THERAVANCE, INC. (US) 2010-10-28 WO disclosed